TICKVALE
>⌘K
NYSE · CIK 0000001800 · PHARMACEUTICAL PREPARATIONS

ABBOTT LABORATORIES

ABT chart by TradingView
P/E 28.6xP/B 3.4xP/SALES 4.0xEV/EBITDA 19.0xFCF YIELD 4.11%

PRICE HISTORY

LIVE · NYSE
ABT chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$44.3B
EBITDA
$11.2B
FREE CASH FLOW
$7.4B
EPS
$3.73
GROSS MARGIN
56.42%
ROIC
11.54%
Q1 FY26ENDED MAR 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

28.6x
+12%
LATEST · Q1 FY26
28.6xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
14.7x222.2x

P / SALES (TTM)

4.0x
+40%
LATEST · Q1 FY26
4.0xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
2.7x6.0x

P / BOOK

3.4x
+22%
LATEST · Q1 FY26
3.4xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
2.5x7.0x

EV / EBITDA (TTM)

19.0x
+33%
LATEST · Q1 FY26
19.0xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
13.4x27.7x

EV / REVENUE (TTM)

4.6x
+53%
LATEST · Q1 FY26
4.6xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
2.8x6.5x

FCF YIELD (TTM)

4.11%
+1.2pp
LATEST · Q1 FY26
4.11%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
2.36%5.00%

DIVIDEND YIELD (TTM)

2.38%
+0.4pp
LATEST · Q1 FY26
2.38%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.71%2.38%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$11.2B
+109%
LATEST · Q1 FY26
11.2BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

EBITDA (DERIVED)

$2.1B
+124%
LATEST · Q1 FY26
2.1BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

NET INCOME

$1.1B
+75%
LATEST · Q1 FY26
1.1BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

EPS (DILUTED)

$0.62
+48%
LATEST · Q1 FY26
0.62Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

REVENUE GROWTH YOY

7.78%
+4.6pp
LATEST · Q1 FY26
7.78%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
-18.06%42.30%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

8.20%
-4.2pp
LATEST · Q1 FY26
8.20%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
4.59%29.15%

RETURN ON CAPITAL

7.91%
-1.5pp
LATEST · Q1 FY26
7.91%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
0.97%24.79%

RETURN ON EQUITY (TTM)

12.06%
+1.0pp
LATEST · Q1 FY26
12.06%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.52%28.12%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN56.20%
OPERATING MARGIN12.05%
NET MARGIN9.65%
FCF MARGIN8.20%
93.6065.1036.598.09-20.41GROSSOPERNETFCFQ2 FY16Q2 FY17Q2 FY18Q2 FY19Q2 FY20Q2 FY21Q2 FY22Q2 FY23Q2 FY24Q2 FY25Q1 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$0.9B
+38%
LATEST · Q1 FY26
0.9BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

STOCK-BASED COMP

$0.3B
+411%
LATEST · Q1 FY26
0.3BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

CAPITAL EXPENDITURE

$0.4B
+62%
LATEST · Q1 FY26
0.4BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

SHARES OUTSTANDING

1.75B
+18%
LATEST · Q1 FY26
1.75BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

DIVIDEND / SHARE

$0.63
+142%
LATEST · Q1 FY26
0.63Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$6.8B
+164%
LATEST · Q1 FY26
6.8BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

TOTAL DEBT

$34.0B
+466%
LATEST · Q1 FY26
34.0BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

DEBT / EBITDA (TTM)

3.1x
+124%
LATEST · Q1 FY26
3.1xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.2x6.0x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 83.34%INSIDERS 0.50%OTHER / RETAIL 16.17%3,830 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.42%145.7M$15.71B-0.8%
Vanguard Capital Management LLC6.53%112.9M$12.18BNEW
State Street Corporation4.60%79.6M$8.58B-0.3%
Capital Research Global Investors2.88%49.8M$5.37B+27.1%
Vanguard Portfolio Management LLC2.77%47.9M$5.17BNEW
Charles Schwab Investment Management, Inc.2.63%45.5M$4.91B+245.0%
Geode Capital Management, LLC2.26%39.1M$4.22B+1.9%
Capital International Investors2.17%37.5M$4.04B-40.7%
Morgan Stanley1.74%30.1M$3.25B-18.0%
Wellington Management Group, LLP1.56%27.1M$2.92B+15.5%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.